Q4 2024 Management View CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, ...

Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the ...